We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Introducing Protocols.io
Industry Insight

Introducing Protocols.io

Introducing Protocols.io
Industry Insight

Introducing Protocols.io

Want a FREE PDF version of This Industry Insight?

Complete the form below and we will email you a PDF version of "Introducing Protocols.io "

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

It could be argued that the way scientists publish and communicate has barely changed for hundreds of years. The Protocols.io web and mobile platform aims to change this by allowing researchers to share and modify up to date protocol knowledge across the globe.

To find out more about this exciting innovation, we spoke to Lenny Teytelman, co-founder of Protocols.io.

JR: You have recently started your first partnership with a commercial force, could you tell us a bit about the development of your platform up to this point?

LT: Protocols.io is open access and free for the research community. It has to be, given the goal of creating a central place with crowd sourced and up-to-date science protocol knowledge. So, the early years of our company were insanely difficult. Building a good web and mobile platform requires capital. Since Protocols.io is free, we had to build it, get content and get scientists to use it – all before we could charge the reagent vendors a dime for the analytics surrounding their reagents. And because what we are doing is different and our business model is new, raising the capital to do this, on a promise of a revenue stream way in the future, was very challenging.

JR: How do you hope the Protocols.io platform will impact the scientific research community?

LT: There is a single hope we are obsessed with – to make research easier and faster for the scientist. We want to minimize the constant re-discovery that plagues our biomedical enterprise. The web was developed at CERN by Tim Berners-Lee in 1989 to facilitate communication between academic researchers. Yet, the way scientists publish and communicate has hardly changed in 350 years. So we are striving to take advantage of the amazing web and mobile technology available today to improve the sharing and discovery of biomedical knowledge.

JR: How did your partnership with New England Biolabs (NEB) come about?

LT: In March of 2014 we ran a Kickstarter campaign for the development of Protocols.io. This was the first successful crowd funding effort aimed at scientists and it attracted a lot of attention. One of the people who noticed was Ryan Ferrell of HDMZ and he reached out with the idea that vendors have high quality protocols that belong in our platform. Ryan instantly saw that seeding the Protocols.io with popular protocols from vendors would be great for scientists, our company and the vendors. Ryan connected us to NEB.

So the short answer is luck/Ryan. We are lucky that Ryan reached out. We are lucky that NEB is such a phenomenal supporter of open access and of efforts to make scientists’ lives easier.

JR: What will your next steps be to expand the reach of your platform and bring more partners on board?

LT: By far, the hardest task for a start-up like ours is to encourage the participation of the research community. There are many labs across the world that have already committed to publishing all of their lab protocols with us, and this is a key partnership. Also, in collaboration with the Hurwitz Lab at the University of Arizona, we are starting on a grant from the Gordon and Betty More Foundation to expand Protocols.io for the viral ecology community.

Of course, the adoption of Protocols.io and its utility to the scientist is directly proportional to the content that we have. The more trusted methods we have in our public repository, the more reason for a scientist to start using us. To this end, we are also working on pilots with several forward-looking biomedical publishers and similarly to NEB, are in conversations with a number of reagent providers to bring their protocols to the platform.

Lenny Teytelman was speaking to Jack Rudd, Editor for Technology Networks.